摘要 |
A symptom of an ocular circulatory condition in a human being is treated by administering an effective amount of 1-[4-ethoxy-3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo-[4,3-d]pyrimidin-5-yl)phenylsulphonyl]-4-methylpiperazine or a pharmaceutically acceptable salt thereof to the human being.
|